Talis Biomedical Corporation Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2017-10-17: Federal exemption Rule 506(b); Types of securities offered Equity; Offer and sale of Series C Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof.; Date of first sale 2017-10-06; Total offering amount $30,000,000.
- 2015-03-06: Federal exemption Rule 506(b); Types of securities offered Equity; Offer and sale of Series B Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof.; Date of first sale 2015-02-19; Total offering amount $30,000,000.
- 2013-08-20: Federal exemption Rule 506; Types of securities offered Equity; Preferred Stock can convert to Common Stock; Date of first sale 2013-06-27; Total offering amount $5,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2017-10-17 | Rule 506(b) | Equity; Offer and sale of Series C Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof. | 2017-10-06 | $30,000,000 | $28,944,628 | $1,055,372 | 9 |
| 2015-03-06 | Rule 506(b) | Equity; Offer and sale of Series B Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof. | 2015-02-19 | $30,000,000 | $26,550,002 | $3,449,998 | 6 |
| 2013-08-20 | Rule 506 | Equity; Preferred Stock can convert to Common Stock | 2013-06-27 | $5,000,000 | $4,000,000 | $1,000,000 | 4 |